The Bone Dysplasia Ontology: integrating genotype and phenotype information in the skeletal dysplasia domain
© Groza et al; licensee BioMed Central Ltd. 2012
Received: 3 October 2011
Accepted: 26 March 2012
Published: 26 March 2012
Skeletal dysplasias are a rare and heterogeneous group of genetic disorders affecting skeletal development. Patients with skeletal dysplasias suffer from many complex medical issues including degenerative joint disease and neurological complications. Because the data and expertise associated with this field is both sparse and disparate, significant benefits will potentially accrue from the availability of an ontology that provides a shared conceptualisation of the domain knowledge and enables data integration, cross-referencing and advanced reasoning across the relevant but distributed data sources.
We introduce the design considerations and implementation details of the Bone Dysplasia Ontology. We also describe the different components of the ontology, including a comprehensive and formal representation of the skeletal dysplasia domain as well as the related genotypes and phenotypes. We then briefly describe SKELETOME, a community-driven knowledge curation platform that is underpinned by the Bone Dysplasia Ontology. SKELETOME enables domain experts to use, refine and extend and apply the ontology without any prior ontology engineering experience--to advance the body of knowledge in the skeletal dysplasia field.
The Bone Dysplasia Ontology represents the most comprehensive structured knowledge source for the skeletal dysplasias domain. It provides the means for integrating and annotating clinical and research data, not only at the generic domain knowledge level, but also at the level of individual patient case studies. It enables links between individual cases and publicly available genotype and phenotype resources based on a community-driven curation process that ensures a shared conceptualisation of the domain knowledge and its continuous incremental evolution.
Skeletal dysplasias are a heterogeneous group of genetic disorders affecting skeletal development. There are currently over 450 recognised types, clustered in 40 groups. Patients with skeletal dysplasias have complex medical issues including short stature, degenerative joint disease, scoliosis and neurological complications. These patients are also a precious resource for biomedical research as they enable scientists to study the effects of single genes on human bone and cartilage development and function. The resulting insights lead to a better understanding of the pathogenesis of more common connective tissue disorders such as arthritis or osteoporosis.
Despite their importance, bone dysplasias are not exploited to their full potential in biomedical research. Since most conditions are rare (< 1:10'000 births) and correct diagnosis is difficult, only a few medical centres worldwide have expertise in diagnosis and management of these disorders. On the other hand, the identification of many skeletal dysplasia genes and subsequent studies of their functions and interactions have led to an explosion of knowledge about bone and cartilage biology. The biomedical literature now contains a large amount of information about individual genes and gene interactions , but it is often difficult to grasp how these interactions work together in a broader context, such as at the growth plate. In turn, the focus on specific cases or genes makes it difficult to identify etiological relationships between skeletal dysplasias, or to recognise clinical or radiological characteristics that are indicative of defects associated with specific molecular pathways.
The International Skeletal Dysplasia Society http://www.isds.ch/ has attempted to address some of these problems with its Nosology of Genetic Skeletal Disorders. Since 1972, the ISDS Nosology lists all recognised skeletal dysplasias and groups them by common clinical-radiographic characteristics and/or molecular disease mechanisms. The ISDS Nosology is revised every 4 years by an expert committee and the updated version is published in a medical journal. The latest version is from 2010 and is presented in . The ISDS Nosology is widely accepted as the "official" nomenclature for skeletal dysplasias within the biomedical community.
While the content of the Nosology is invaluable, the format of the Nosology has several shortcomings. Firstly, the classification scheme is inflexible, each disorder is listed in one group, based either on its clinical radiographic appearance or on its underlying molecular genetic mechanism (many disorders can be associated with multiple groups). Secondly, very limited information is listed for each entry. Current information is limited to: the OMIM  number, the chromosome locus, gene name and protein name. In other words, the Nosology is not linked to freely available and widely used online repositories such as UniProt , limiting users' ability to further study the disorders. Thirdly, the Nosology associates diseases with specific genes but provides no additional information on the responsible gene mutations. Fourthly, phenotypic and clinical-radiographic information is present intrinsically in the classification, but not explicitly in the Nosology. Finally, due to its current publishing process, the content quickly becomes outdated, as genes or disorders discovered after the publication date cannot be included until the next revision (4 years later). For example, shortly after the publication of the newest version of the ISDS Nosology, Gray et al.  have shown that the Serpentine fibula polycystic kidney syndrome (SFPKS) is characterised by truncating mutations in NOTCH2, and consequently have proposed the move of SFPKS from the Filamin Group to the Osteolysis Group, due to its genetic similarities with the Hajdu-Cheney syndrome. Unfortunately, this information will be reflected in the Nosology only in four years time.
Over the past 10 years, ontologies have proven to represent a practical solution to data integration and knowledge acquisition, processing and management, particularly in the Healthcare and Life Sciences . Their use in automated annotation [7, 8] or cross-linking for query and retrieval purposes [9, 10] is now broadly recognised in the biomedical field. As a result of their wide adoption and in order to enable collaboration and cross-fertilisation, several ontology repositories and collections have been created. The Open Biomedical Ontologies Foundry http://www.obofoundry.org/ represents the most prominent collaborative collection of biomedical ontologies, while the NCBO BioPortal http://bioportal.bioontology.org/ is currently the most comprehensive ontology repository in this domain. Ontologies hosted in or linked from these two access points vary widely in size (ranging from several hundreds to hundreds of thousands of concepts) and domain (from imaging methods to cell behaviour or clinical terminology). While an extensive number of biomedical topics have been covered, there remain topics where more comprehensive documentation is required. One such topic is the skeletal dysplasia domain.
The Bone Dysplasia Ontology aims to complement the spectrum of existing ontologies and address the specific knowledge representation shortcomings of the ISDS Nosology. Its main role is to provide the scaffolding required for a comprehensive, accurate and formal representation of the genotypes and phenotypes involved in skeletal dysplasias, together with their specific and disease-oriented constraints. As opposed to the current ISDS Nosology, the ontology enables a shared conceptual model, formalised in a machine-understandable description, in addition to a continuous evolution and a foundational building block for facilitating knowledge extraction and reasoning. The symbiosis between the ontology and the community-driven knowledge curation platform built to support its evolution enables collaborative and incremental acquisition and encoding of advances by the experts in the field. Ultimately, it underpins mechanisms for sharing and re-use of data and information and advanced reasoning techniques for semi-automated diagnosis or disease features extraction.
The Bone Dysplasia Ontology has been built collaboratively by a team of experts in skeletal dysplasias and ontology engineering. The design of the ontology was heavily influenced by the need to address the limitations of the ISDS Nosology, or more concretely, the need to capture the wealth of intrinsic knowledge of the domain described in diverse case studies or publications. Hence, the main purpose of the ontology coincides with its implicit role of providing a shared conceptualisation of the domain, and is not necessarily dependent on specific use cases. The community-driven knowledge curation platform built to support the ontology (described later in the article) enables a knowledge engineering cycle that combines a sustainable ontology evolution and quality-oriented process (enforced by the editorial roles embraced by the experts in the community) with the direct use of the ontology for semantic annotation of clinical summaries and collaborative decision-making.
In order to avoid ambiguous interpretation and to enable compatibility between Bone Dysplasia Ontology concepts and concepts from other ontologies, the top level classes are rooted in entities defined by the Basic Formal Ontology (BFO, http://www.ifomis.org/bfo, and where possible by the Ontology of General Medical Science (OGMS) --a middle ontology rooted in BFO, which provides a specific framework for medicine, to be extended by specialised ontologies. The concept mappings are listed in the following: (i) Bone Dysplasia represents a ogms:OGMS_0000047 (Genetic disorder), (ii) Gene is a snap:MaterialEntity; (iii) Gene Mutation represents snap:SpecificallyDependentContinuant(s) as every gene mutation is specific to a particular gene; (iv) Phenotypic Composite represents a ogms:OGMS_0000023 (Phenotype).
The Bone Dysplasia, Gene and Protein terms were manually extracted from the 2010 Revision of the ISDS Nosology . Gene classes were also augmented with references to external resources, such as MeSH http://www.nlm.nih.gov/mesh/, OMIM or Uniprot. Gene Mutation descriptions were designed according to the Mutation Nomenclature of the Human Genome Variation Society , to capture the offset of the mutation and the original and mutated content. For example, GLY380ARG, 1138 G-A has a NCI: Missense Mutation type attached, an offset of 1138, count 1, original content G and mutated content A.
The current import of all external concepts followed the minimum information to reference an external ontology term (MIREOT) guidelines . The platform sustaining the evolution of the ontology will ensure that the import of any additional external concepts will respect the same guidelines.
The structure of the ontology is a directed acyclic graph (DAG) based on taxonomical relations and using the rdfs:subClassOf construct. All classes have fully qualified URIs, while the human-readable description is provided via the rdfs:label property. Alternative definitions (e.g., synonyms or acronyms), in addition to references to external entities are defined by existing or custom OWL annotation properties, such as skos:altLabel, chromosomal_locus, uniprot_id, omim_no or mesh_id. The metadata describing the ontology is represented using the DublinCore vocabulary http://purl.org/dc/terms/ and its defined properties: dc:title, dc:creator, dc:contributor and dc:publisher.
We have formalised the ontology using OWL-DL , one of the three sub-languages of the Web Ontology Language (OWL) because it provides a maximum expressiveness without losing computational completeness. OWL-DL defines constructs that enable: (i) boolean combinations of class expressions (such as union or intersection, required to integrate diverse vocabularies for describing the phenotype information); (ii) as well as disjointness and equivalence class axioms; and (iii) arbitrary cardinality restrictions. Furthermore, the sublanguage has also developed a wide range of mature reasoners, which makes it an ideal candidate for real-world practical applications.
From a pragmatical perspective, we opted for using a logical formalism, because only a well-structured, logical representation framework is able to encode the relations existing between phenotypic and genotypic characteristics in the context of particular bone dysplasias. The resulting class axioms not only encode properly the conceptual real-world knowledge of the domain (e.g., Achondoplasia is characterized by a mutation in gene FGFR3 and by Hydrocephalus or Lumbar hyperlordosis), but also enable us to use this conceptual knowledge to perform reasoning on patient instance data.
The Bone Dysplasia Ontology was curated manually using the Stanford Protege-OWL 4.1 http://protege.stanford.edu/ ontology editor. For reasoning purposes, the ontology imports (via owl:imports statements) the Human Phenotype Ontology and the Phenotype and Trait Ontology, but also specific concepts from different other ontologies, as specified above and further described in the following section. The consistency checking has been performed by running the OWL-DL Pellet v2.1.2  and Hermit v1.3.3  reasoners over the ontology, to analyse both the class and object property definitions.
Results and discussion
This section details the classes defined by the Bone Dysplasia Ontology and the class axioms and relations that we have introduced in order to accurately model the existing knowledge in the domain. It also discusses the availability of the ontology and our envisioned revision and extension cycle.
The Bone Dysplasia Ontology classes
The structure of the ontology is conceptually built around three main knowledge pillars: bone dysplasias, genotype information and phenotype information, as depicted in Figure 1. The ontology consists of 1228 own-defined classes, of which 515 define bone dysplasias, 254 define genes, 361 define gene mutations and 224 define proteins.
Similar or equivalent bone dysplasia concepts, including a HP_0002652 (Skeletal dysplasia) super-concept, are also defined by the Human Phenotype Ontology. However, a correct alignment between these terms and the terms defined within our ontology, both from the domain and the logical perspectives, cannot be realised due to either the vagueness or the improper granularity of the concepts. For example, HP defines concepts such as HP_0005716 (Lethal skeletaldysplasia) or HP_0005685 (Severe skeletal dysplasia), which seem to be rather qualities than proper disease definitions. Similarly, concepts like HP_0002654 (Multiple epiphyseal dysplasia), are defined in our ontology at a much more fine-grained level via several concepts, e.g., in this case via seven classes (see Multiple epiphyseal dysplasia and pseudoachondroplasia Group).
Gene mutations are defined according to the Mutation Nomenclature of the Human Genome Variation Society , to capture the offset of the mutation, along with the original and mutated content, via four datatype properties: original_content, offset, count and mutated_content. The type of the mutation is signalled by the mutation_type relation between Gene Mutation and NCI:Mutation Abnormality, the latter concept being imported in our ontology together with its entire sub-structure (see below for a gene mutation example). Gene concepts are linked to multiple external resources, e.g., OMIM, Uniprot or MeSH via corresponding annotation properties: omim_no, uniprot_id, mesh_id, umls_cui, ref_seq, entrezgene_id and accesion_no.
As a side remark, the ontology contains a second Gene Mutation class, imported from the NCI thesaurus as part of the NCI:Mutation Abnormality sub-tree. The BDO and the NCI Gene Mutation classes are not equivalent. The BDO Gene Mutation is an entity that describes actual gene mutations (linked to a Gene and having a type, encoding, offset, etc.). The NCI Gene Mutation is, in reality, improperly defined because it refers to a type of mutation and not to a gene mutation per se. This can be easily observed by analysing the concepts imported from NCI under the NCI:Mutation Abnormality super-concept, which describe different types of gene mutations. However, since we rely on these mutation type concepts and import them according to the MIREOT principle, we were not able to omit this particular concept, and hence to avoid confusion.
The phenotype information (depicted in Figure 2) is recorded in a highly extensible manner via the main class Phenotypic Composite. The complex nature of skeletal dysplasias can be observed in particular in the wide range of clinical and radiographic characteristics manifested by patients. Consequently, we opted for re-using concepts from known ontologies that subsume most of the possibly arising phenotype information in patient records, e.g., REAMS:Abnormality for radiographic features and HP:HP_0000118 (Phenotypic abnormality) for other phenotypic findings. As discussed earlier, our Phenotypic Composite class represents a composite element that connects conceptually an otect FMA:Anatomical entity or an Anatomical Composite to a PATO:Physical Object Quality or a Quality Composite using the describes and has_quality relations, or can build upon existing composites via the OBO has_part relation in addition to connecting a PATO:Physical Object Quality or a Quality Composite via the has_quality relation. The FMA:Anatomical entity and PATO:Physical Object Quality concepts have been imported in our ontology, however, choosing particular sub-concepts and specialising their relations to particular dysplasias is deferred to the community and supported by the platform described later in the paper. Hence, Phenotypic Composite carries a scaffolding role onto which particular elements can be created to complement the gaps in the current phenotype ontologies. Some definition examples are, however, presented both in the ontology, as well as in the following section.
Class axioms and relationships
Relations defined in the Bone Dysplasia ontology
Phenotypic Composite, Gene Mutation
HP:HP_0000118 (Phenotypic abnormality)
HP: HP_0000005 (Mode of inheritance)
Anatomical Composite, FMA:Anatomical_Entity
PATO:PATO_0001241(Physical object quality)
PATO:PATO_0001241(Physical object quality)
A major aim of the Bone Dysplasia ontology is to underpin a community-driven knowledge curation platform that enables collaborative decision making and knowledge exchange among the experts in the field. In order to support the decision making process (i.e., collaborative diagnosis), as well as the transfer of knowledge from particular patient studies to the generic concept definitions, we encoded the semantics of the emerging knowledge discoveries in class axioms and restrictions. Furthermore, to reflect the current domain knowledge about each specific dysplasia accurately, these class axioms are specialised at the lower levels of the Bone Dysplasia concept with more specific details. As a result, more than 70% of actual bone dysplasia concepts are linked to gene mutations, and around 80% of the same concepts have phenotype information attached (via more than 2,000 phenotypes imported from the Human Phenotype Ontology). The lack of class axioms in the rest of the bone dysplasia concepts is due, in principle, to two factors. From the genetic perspective, the corresponding bone dysplasias currently have no established links with particular genes, while from the phenotype perspective, we were, until now, unable to mine disorder--phenotype relations for the corresponding bone dysplasias.
The class definition of three of the top-level concepts (as Gene is an independent material entity) are presented below, using the OWL Manchester syntax:
characterized_by only (REAMS:Abnormality or HP:HP_0000118
or Phenotypic_Composite or Gene_Mutation)
mode_of_inheritance only HP:HP_0000005
skos:description "A genetic disorder that involves abnormal
development of bones and connective tissues."
Definition: Bone_Dysplasia is defined as a specialisation is defined as a specialisation has two restrictions: (i) all concepts that characterise this entity (via characterized_by) are Gene_Mutation s or Phenotypic_Composite s, or REAMS:Abnormality or HP:HP_0000118 (Phenotypic abnormality), and (ii) all concepts providing a mode_of_inheritance for this entity are HP:HP_0000005 (Mode of inheritance).
has_locus only Gene and has_locus some Gene
mutation_type only NCI:Mutation_Abnormality
and mutation_type some NCI:Mutation_Abnormality
skos:description "A change or alteration in a gene."
Definition: Gene_Mutation is defined as a specialisation of an entity that has two restrictions: (i) all concepts acting as a locus for this entity (via has_locus) are Gene s and there is at least one such Gene that is the locus of this entity, and (ii) all concepts that define the mutation_type for this entity are NCI:Mutation_Abnormality and there is at least one such NCI:Mutation_Abnormality that provides a mutation type.
(has_part some Phenotypic_Composite
and has_part only Phenotypic_Composite)
(describes some FMA:Anatomical_entity
and describes only FMA:Anatomical_entity)
(describes some Anatomical_composite
and describes only Anatomical_composite)
(has_quality only PATO_0001241
and has_quality some PATO_0001241)
(has_quality only Quality_Composite
and has_quality some Quality_Composite)
skos:description "A continuant describing the conjunction
between a quality and an anatomical part or an anatomical
Definition: Phenotypic_Composite is defined as a specialisation of an entity that has two restrictions: (i) the entity either has_part some concepts that are all Phenotypic_Composite and there exist at least one such Phenotypic_Composite that is a part of the entity, or all concepts described by this entity (via describes) are FMA:Anatomical_entity and there is at least one such FMA:Anatomical_entity that is described by the entity, or all concepts described by this entity (via describes) are Anatomical_Composite and there is at least one such Anatomical_Composite that is described by the entity, and (ii) all concepts that define a quality for this entity (via has_quality) are PATO:PATO_0001241 and there is at least one such PATO:PATO_0001241 that provides a quality, or all concepts that define a quality forthis entity (via has_quality) are Quality_Composite and there is at least one such Quality_Composite that provides a quality.
Below, we illustrate a series of concrete concept definition examples, for the Achondroplasia and GM0000001 classes and two particular Phenotypic Composite s--Translucency of proximal femur and Oval translucency of proximal femur, by showing the some of the definition constraints, and in the case of the gene mutation, the information captures along the lines of the Mutation Nomenclature of the Human Genome Variation Society:
characterized_by only (GM000001 or GM000361
or HP_0000238 or HP_0002938 or HP_0002968 or HP_0003505 or ...)
mode_of_inheritance only HP_0000006 and
mode_of_inheritance some HP_0000006
has_locus only G0000001 and has_locus some G0000001
mutation_type only NCI:Missense_Mutation and
mutation_type some NCI:Missense_Mutation
encoding "GLY380ARG, 1138 G-A", offset 1138,
original_content "G", mutated_content "A"
describes only AC_0000001 and describes some AC_0000001
has_quality only PATO:PATO_0001354 and1
has_quality some PATO:PATO_0001354
label "Translucency of proximal femur"
skos:description "Translucent proximal area of femur"
has_part only FMA:Femur and has_part some FMA:Femur
has_anatomical_coordinate only FMA:Proximal and
has_anatomical_coordinate some FMA:Proximal
label "Proximal femur"
skos:description "The proximal area of the femur"
describes only AC_0000001 and describes some AC_0000001
has_quality only QC_0000001 and has_quality some QC_0000001
label "Oval translucency of proximal femur"
skos:description "Oval-shaped translucent area of the proximal femur"
has_part only PATO:PATO_0001354 and
has_part some PATO:PATO_0001354
has_qualifier only PATO:PATO_0000947 and
has_qualifier some PATO:PATO_0000947
label "Oval translucency"
skos:description "Oval-shaped area of translucency"
Bone Dysplasia Ontology fact sheet
Bone Dysplasia Ontology
skeletal dysplasias, genes, proteins,
gene mutations and phenotypic
characteristics in human
Number of classes
HP, PATO, NCI (Gene mutation types)
rdfs:label, skos:altLabel, uniprot_id
entrezgene_id, ref_seq, mesh_id, locus,
omim_no, umls_cui, accession_no
The design of the ontology aims to re-use and adopt existing vocabularies in order to minimize the re-invention, duplication and overlap of concepts. Consequently, the ontology imports, following the MIREOT guidelines , a series of concepts from external resources, as previously discussed. Additionally, the Gene concepts include references to OMIM, Uniprot, MeSH, and UMLS via corresponding annotation properties, while the Bone Dysplasia concepts refer to OMIM and MeSH.
Revising and extending the Bone Dysplasia Ontology
The Bone Dysplasia ontology has been built as a foundation block for SKELETOME--the skeletal dysplasia knowledge curation platform (described in the following section). As such, support for extensibility is important, to cope with the complex and evolving nature of the field. Consequently the SKELETOME platform has been designed to enable roundtrip knowledge engineering, which assumes the evolution of the ontology. New discoveries emerging from patient studies will be easily transferred at the conceptual level by domain experts (via class axioms) through extensions to the ontology and through additional semantic inference rules, as well as at the instance level as new case data becomes available. In addition to refined class definitions via specialised restrictions, the platform allows users with editorial roles to alter the bone dysplasia classification, by creating or deleting groups, or by moving diseases between groups. This leads to a continuous evolution of the ontology and inherently of the Nosology and bone dysplasia knowledge.
Comparison to related ontological resources
Among the three pillars of the Bone Dysplasia ontology, the actual skeletal dysplasia knowledge (representing the core of the ontology) is covered only superficially in other ontologies and vocabularies. Examples such as the Systematized Nomenclature of Medicine--Clinical Terms (SNOMED-CT, http://www.ihtsdo.org) , REAMS, the NCI Thesaurus  or the Human Disease Ontology include, as also highlighted in the Background section, only high level concepts denoting the most commonly known dysplasias. None of these existing related vocabularies attempt to capture related genotype or phenotype information. The added value of the Bone Dysplasia ontology stands in the comprehensive classification of these disorders, in addition to an accurate descriptions (via class axioms and relations) of their main genetic and phenotypic characteristics. We regard the other ontologies, in particular REAMS, SNOMED and the NCI thesaurus, as effective complements and important resources to be cross-referenced and re-used (to avoid redundancy) to describe the phenotype and genotype information of bone dysplasias.
To date, the integrity of the ontology has been ensured by the domain experts-driven curation. Future testing of its applicability will be evidenced by the extent of its changes over time and the future growth of the SKELETOME knowledge base and its associated community of users.
Community-driven knowledge curation
The increasing use of ontologies in Healthcare and Life Sciences has led to novel ways of processing digital content, which in turn have introduced new possibilities of dealing with scientific publications and data . Such content processing techniques make knowledge more open and exploitable than ever before [8, 26].
Our focus is on ensuring a continuous enrichment and evolution of the ontology by transferring knowledge present in existing and emerging patient case studies into class axioms or cross-references to external phenotype ontology concepts. In order to achieve this, we developed the SKELETOME platform http://skeletome.metadata.net/skeletome, a community-driven knowledge curation platform that enables collaborative input, sharing and re-use of data and information among experts in the skeletal dysplasia domain. SKELETOME provides a central access point to a rich skeletal dysplasia knowledge base, supported by low-level features, such as user and group-based access and privacy control. At the same time, from a high-level perspective, the anonymised pool of case studies enables statistical inference for knowledge discovery purposes or computer-assisted diagnosis.
SKELETOME is built as a Drupal 7 http://drupal.org/ instance, thus inherently providing the collaborative aspects, and also allowing us to develop custom modules to suit our needs. The Bone Dysplasia Ontology acts as the knowledge back-bone of the platform. Each of the disease concepts present in the hierarchy of skeletal dysplasias has been imported, via its own module, into the platform and has an associated human-readable page. The system structure is similar to a knowledge Wiki that is built around the ontology. The user-friendly page corresponding to each dysplasia, presents a summary of the dysplasia and contains pointers to external references. Registered members of the community can add facts grounded in scientific publications (similar to the OMIM structure) and can discuss facts added by other members. Members with editorial role have the ability of editing the summary of dysplasias by incorporating the facts widely accepted by the community. They are also able to alter the bone dysplasia pages by, for example, moving them between groups. Such operations have a direct impact on the ontology and are immediately reflected in the underlying knowledge base. The continuous logical correctness of the ontology is always enforced by the platform, without the experts noticing it. In practice, we have created a round-trip knowledge engineering process, driven by the experts in the community (only a few experts have editorial roles) who are not required to possess any ontology engineering skills.
The SKELETOME platform and knowledge-base, underpinned by the Bone Dysplasia ontology, represents an ideal approach by which experts in the skeletal dysplasias domain can collaboratively document, expand and maintain a curated body of the knowledge which will lead to accelerated innovation and scientific breakthroughs in their field.
The Bone Dysplasia ontology described in this paper, represents the most comprehensive structured knowledge source for the skeletal dysplasias domain. It provides the means for integrating and annotating clinical and research data, not only at the generic domain knowledge level, but also at the level of individual patient case studies--by enabling links between individual cases and publicly available genotype and phenotype resources. The community-driven curation process ensures a shared conceptualisation of the domain knowledge and its continuous incremental evolution. Future development of both the ontology and the SKELETOME platform will focus on advancing the reasoning and knowledge extraction services--which will hopefully lead to the discovery of previously unknown relationships between gene mutations, phenotype characteristics and bone dysplasias and the discovery of new drugs to combat disorders associated with human bone and cartilage development.
This research is funded by the Australian Research Council (ARC) under the Linkage grant SKELETOME--LP100100156. We wish to thank Yuan-Fang Li, Hasti Ziamatin and Razan Paul for their input in designing the ontology. Especial thanks also to Tania Tudorache, Timothy Redmond and Matthew Horridge for the extremely useful feed-back on the logical correctness of the class axioms and of the grounding in BFO.
- Ashburner M, et al.: Gene ontology: tool for the unification of biology. Nat Genet 2000, 25: 25–29. 10.1038/75556PubMed CentralView ArticlePubMedGoogle Scholar
- Warman ML, et al.: Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet A 2011, 155(5):943–968. 10.1002/ajmg.a.33909PubMed CentralView ArticleGoogle Scholar
- Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA: Online mendelian inheritance in man (OMIM), a knowledge base of human genes and genetic disorders. Nucleic Acids Res 2005, 33: 514–517.View ArticleGoogle Scholar
- Bairoch A, et al.: The universal protein resource (UniProt). Nucleic Acids Res 2005, 33: 154–159.View ArticleGoogle Scholar
- Gray MJ, Kim CA, Bertola DR, Arantes PR, Stewart H, Simpson MA, Irving MD, Robertson SP: Serpentine fibula polycystic kidney syndrome is part of the phenotypic spectrum of Hajdu-Cheney syndrome. Eur J Hum Genet 2012, 20(1):122–4. 10.1038/ejhg.2011.125PubMed CentralView ArticlePubMedGoogle Scholar
- Ruttenberg A, Rees JA, Samwald M, Marshall MS: Life Sciences on the Semantic Web: the neurocommons and beyond. Brief Bioinform 2009, 10(2):193–204. 10.1093/bib/bbp004View ArticlePubMedGoogle Scholar
- Cui H: Semantic annotation of morphological descriptions: an overall strategy. BMC Bioinforma 2010, 11: 278. 10.1186/1471-2105-11-278View ArticleGoogle Scholar
- Roberts A, Gaizauskas R, Hepple M, Demetriou G, Guo Y, Roberts I, Setzer A: Building a semantically annotated corpus of clinical texts. J Biomed Inform 2009, 42(5):950–966. 10.1016/j.jbi.2008.12.013View ArticlePubMedGoogle Scholar
- Kemper B, Matsuzaki T, Matsuoka Y, Tsuruoka Y, Kitano H, Ananiadou S, Tsujii J: PathText: a text mining integrator for biological pathway visualizations. Bioinformatics 2010, 26(12):i374-i381. 10.1093/bioinformatics/btq221PubMed CentralView ArticlePubMedGoogle Scholar
- Mueller HM, Kenny EE, Sternberg PW: Textpresso: an ontology-based information retrieval and extraction system for biological literature. PLoS Biol 2004, 2(11):e309. 10.1371/journal.pbio.0020309View ArticleGoogle Scholar
- Smith B, et al.: The OBO foundry: coordinated evolution of ontologies to support biomedical data integration. Nat Biotechnol 2007, 25: 1251–1255. 10.1038/nbt1346PubMed CentralView ArticlePubMedGoogle Scholar
- Noy NF, et al.: BioPortal: ontologies and integrated data resources at the click of a mouse. Nucleic Acids Res 2009, (37 Web Server):W170-W173.Google Scholar
- Grenon P, Smith B, Goldberg L: Biodynamic Ontology: Applying BFO in the Biomedical Domain. In Ontologies in Medicine. Edited by: Pisanelli DM. IOS Press, The Netherlands; 2004:20–38.Google Scholar
- Scheuermann RH, Ceusters W, Smith B: Toward an Ontological Treatment of Disease and Diagnosis. In Proceedings of the 2009 AMIA Summit on Translational Bioinformatics. San Francisco; OmniPress; 2009:116–120.Google Scholar
- den Dunnen JT, Antonarakis SE: Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000, 15: 7–12. 10.1002/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-NView ArticlePubMedGoogle Scholar
- Mabee PM, Ashburner M, Cronk Q, Gkoutos GV, Haendel M, Segerdell E, Mungall C, Westerfield M: Phenotype ontologies: the bridge between genomics and evolution. Trends Ecol Evol 2007, 22(7):345–350. 10.1016/j.tree.2007.03.013View ArticlePubMedGoogle Scholar
- Robinson PN, Kohler S, Bauer S, Seelow D, Horn D, Mundlos S: The human phenotype ontology: a tool for annotating and analyzing human hereditary disease. Am J Hum Genet 2008, 83(5):610–615. 10.1016/j.ajhg.2008.09.017PubMed CentralView ArticlePubMedGoogle Scholar
- Gkoutos GV, Mungall C, Doelken S, Ashburner M, Lewis S, Hancock J, Schofield P, Koehler S, Robinson PN: Entity/Quality-Based Logical Definitions for the Human Skeletal Phenome using PATO. In Proceedings of the 31st Annual International Conference of the IEEE EMBS. Minneapolis; IEEE Press; 2009:7069–7072.Google Scholar
- Rosse C, Mejino JLV: A reference ontology for biomedical informatics: the foundational model of anatomy. Trends Ecol Evol 2003, 36(6):478–500.Google Scholar
- Courtot M, Gibson F, Lister AL, Malone J, Schober D, Brinkman RR, Ruttenberg A: MIREOT: the minimum information to reference an external ontology term. Applied Ontology 2011, 6(1):23–33.Google Scholar
- Dean M, Schreiber G: OWL Web Ontology Language Reference, W3C Recommendation.2004. [http://www.w3.org/TR/owl-ref/]Google Scholar
- Sirin E, Parsia B, Grau BC, Kalyanpur A, Katz Y: Pellet: a practical OWL-DL reasoner. Web Semantics: Science, Services and Agents on the World Wide Web 2007, 5: 51–53. 10.1016/j.websem.2007.03.004View ArticleGoogle Scholar
- Motik B, Shearer R, Horrocks I: Optimized Reasoning in Description Logics using Hypertableaux. In Proceedings of the 21st Conference on Automated Deduction (CADE-21). Bremen: Springer; 2007:67–83.View ArticleGoogle Scholar
- Spackman KA: SNOMED RT and SNOMED CT. Promise of an international clinical terminology. MD Comput 2000, 17(6):29.PubMedGoogle Scholar
- Hartel FW, de Coronado S, Dionne R, Fragoso G, Golbeck J: Modeling a description logic vocabulary for cancer research. J Biomed Inform 2005, 38(2):114–129. 10.1016/j.jbi.2004.09.001View ArticlePubMedGoogle Scholar
- Wermter J, Tomanek K, Hahn U: High-performance gene name normalization with GeNo. Bioinformatics 2009, 25(6):815–821. 10.1093/bioinformatics/btp071View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.